---
title: "Lvtaiyang Pharma · Fuzhiqing OTC E-commerce Case — Nine Health"
url: https://www.nine-health.cn/en/cases/lvtaiyang-fuzhiqing/
lang: en-US
publisher: "和众利健科技（深圳）有限公司"
contact: "18126259547"
updated: 2026-09-09
---

# Lvtaiyang Pharma · Fuzhiqing OTC E-commerce Case — Nine Health

Driven by differentiated brand positioning, hero-SKU breakthroughs, an omni-channel matrix and compliance review, powering refined multi-SKU growth.

## In One Sentence
Driven by differentiated brand positioning, hero-SKU breakthroughs, an omni-channel matrix and compliance review, powering refined multi-SKU growth.

## Project Background
Fuzhiqing ointment is a Miao-medicine OTC traditional Chinese patent drug from Guizhou Lvtaiyang Pharma. The project had to build brand awareness, coordinate multiple specs and product lines, and hold a unified price system across platform campaigns — all while strictly complying with drug advertising and platform rules.

## Engagement Overview
- Period: Jan 2024 — Dec 2026
- Core product: Fuzhiqing ointment 10g, 7.5g×2, etc.
- Channels: Alibaba/JD self-operated, Tmall/JD flagship, tier-2 distribution, instant retail
- Scope: E-commerce operations, content marketing, compliance review, channel expansion

## Operations Strategy
- **Differentiated Brand Positioning**: Build a unified visual and content expression around the Guizhou Miao-medicine and TCM brand assets, forming a clear identity within compliance boundaries.
- **Hero-SKU Breakthrough**: Anchor on the 10g Fuzhiqing ointment as the traffic and hero SKU, then let larger specs, related items and bundles carry basket size and attach rate.
- **Omni-channel Matrix**: Self-operated stores carry scale, flagship stores capture brand search and members, distribution widens reach, and instant retail covers the immediate-purchase scenario.
- **Compliance & Price-Control Base**: Unified creative review, campaign approval, a minimum-price red line and a daily inspection mechanism keep the growth process stable and sustainable.

## Phased Operating Results
- **Store GMV**: 100k → 500k (5×)
- **Hero-SKU volume**: 80k → 420k (5×+)
- **Search & brand-term index**: 3,000 → 30,000 (10×)
- **Conversion rate**: 12% → 25% (+108%)
- **Avg. order value**: 63 RMB → 93 RMB (+48%)
- **ROAS**: 3.5 → 6.5 (+86%)
- **Repurchase rate**: 6% → 12% (+100%)

## Provider
Nine Health Technology (Shenzhen) Co., Ltd. — 20+ years in pharmaceutical marketing. Phone: +86-18126259547. More cases at /en/cases/.

---

Source: [Nine Health](https://www.nine-health.cn/en/cases/lvtaiyang-fuzhiqing/) · Publisher: 和众利健科技（深圳）有限公司 · Phone: +86-18126259547